Development and modifications are described that expand the application of an immunoassay from the detection of Kanechlors (Japanese technical PCBs mixtures) to the detection of Aroclors (U. S. technical PCB mixtures, used in Korea) in contaminated Korean transformer oil. The first necessary modification was the development of a new antibody with a reactivity profile favorable for Aroclors. The second modification was the addition of a second column to the solidphase extraction method to reduce assay interference caused by the Korean oil matrix. The matrix interference is suspected to be caused by the presence of synthetic oils (or similar materials) present as contaminants. The modified assay was validated by comparison to high-resolution gas chromatography/high-resolution mass spectrometry analysis, and was shown to be tolerant of up to 10% of several common synthetic insulating oils. Finally the screening performance of the modified assay was evaluated using 500 used transformer oil samples of Korean origin, and was shown to have good performance in terms of false positive and false negative rates. This report provides evidence for the first establishment of immunoassay screening for Aroclor based PCB contamination in Korean transformer oil.
Introduction
Commercial production and new use of polychlorinated biphenyls (PCBs) have been prohibited in Japan since 1973, 1 in the United States (U. S.) since 1976 2 and had ceased worldwide by 1993. 3 As of 2013, 179 countries are party to the Stockholm Convention on Persistent Organic Pollutants, which commits them to phase out the use of PCBs completely by 2025, and bring remaining PCBs under environmentally sound waste management by 2028. 4 Atmospheric PCB levels have been declining exponentially with a half-life of about 8.5 years since the early 1990's, 5, 6 but there remains a reservoir of "contained" PCBs, mainly in electrical transformers and capacitors, the exact size of which is unknown, but believed to be large. 7 Regulations concerning PCBs in transformer oil vary by country. For example, Japan has adopted the lowest regulatory concentration (a maximum residue limit, MRL, of 0.5 ppm of total PCBs), and has mandated that all transformers in Japan must be screened for PCBs and those found contaminated be cleaned or destroyed. Korea is currently moving along a similar course, albeit with a somewhat less stringent MRL of 2 ppm. These ambitious programs to locate and eliminate contaminated transformer oil require cost-effective large-scale testing.
Therefore, a rapid and low-cost measurement method for PCBs in oil was needed.
Our laboratory has been involved for several years in developing and optimizing parameters for an immunoassay system suitable for screening transformer oil samples for the presence of PCB mixtures. [8] [9] [10] [11] [12] [13] [14] [15] [16] All of our prior work has been focused on Kanechlors (Japanese technical PCB mixtures), which are analogous, but not identical, to U. S. technical PCB mixtures known as Aroclors. Previously described Aroclor immunoassays suffer from ambiguous results due to the antibody's differing reactivity to various Aroclors. [17] [18] [19] In order to resolve the ambiguity problem, an antibody suitable for screening (on the basis of reactivity to each Aroclors) must be chosen.
Another requirement for an immunoassay system to screen oil samples for the presence of Aroclors is a suitable pretreatment and extraction method. The pretreatment method must be independently constructed for the purpose, depending upon the samples and antibody, because the matrix affecting the antibody performance in the samples is not always identical to every case. There is no guarantee that the pretreatment for Japanese oil is applicable to Korean oil and to the antibody towards Aroclors. No information concerning adequate pretreatment for the detection of Aroclors in Korean transformer oil using an immunoassay is available at present.
In this report we focus on Korea, where Aroclors were used in transformer oil. In particular we report on a new antibody with a favorable reactivity profile for use with Aroclors, and an extraction procedure suitable for use with synthetic oils and high sample throughput (80 samples per day). In addition we present screening data from 500 used transformer oil samples of Korean origin. The screening data show that the modified biosensor can be usefully employed in the Korean regulatory environment.
Experimental

Safety considerations
PCBs represent a significant health threat, and Aroclor mixtures were treated as dangerous poisons. All personnel wore nitrile gloves when handling PCB containing samples. All PCB samples were kept in a secure area, and pure Aroclors were kept in a locked cabinet. Oleum impregnated columns were used in a fume hood. All PCB contaminated glassware and solutions were turned over to a (Japanese) government-approved contractor for disposal.
Reagents and chemicals
Keyhole 
Antibody
PCBs were synthesized with a pentane linker terminating in a maleimide group at position 5′ of the PCB. Chromatographic analysis (not shown) suggested a chlorine distribution of the synthesized molecules, consisted mainly of PCB 3,4,2′,4′,6′ with smaller amounts of PCB 4,2′,4′,6′ and PCB 2,4,2′,4′,6′, in agreement with a previous report. 20 The maleimide group on the synthesized molecule was covalently linked to KLH, and the compound was purified using a dechlorination column with PBS (pH 7.4) following previously reported procedures. 21 For the immunization, three six-week-old female mice (all animals were maintained in accordance with the guidelines of Animal Experimentation of the Central Research Institute of Electric Power Industry) were injected intraperitoneally with 200 μg of a purified mixture in adjuvant (TiterMax Gold CytRx, GA). Second injections were given three weeks after the first injection. Third injections were given two weeks after the second injection. One week after the third injection, blood samples were drawn and centrifuged for 1 min at 10000 rpm to collect sera. The reactivity values of the sera to a mixture of Aroclor 1242, 1248, 1254, and 1260 were analyzed by a KinExA 3000 instrument from Sapidyne Instruments Inc. (ID) based on their ability to bind to a chlorinated phenyl BSA complex, described previously. [8] [9] [10] Briefly, it is based on kinetic exclusion immunoassay, and consists of a capillary flow cell in a filter fluorometer with the means to automatically replace immunoactive solid-phase particles and flow samples. A mouse whose serum gave the highest signal by KinExA was selected, and was given a final booster shot. Four days thereafter, spleen cells fused with myeloma cells using polyethylene glycol 1500 and the cells were cultured in ten 96-well flat-bottomed microculture plates for 10 days. Positive hybridoma cells were screened for reactivity to each of the four kinds of Aroclors (Ar1242, Ar1248, Ar1254, and Ar1260) as previously described. 21 Next, the selected hybridoma cell was cloned by colony formation using methylcellulose semisolid medium (ClonaCell-HY, Stemcell Technologies Inc., Vancouver, Canada). Ascitic fluid was produced in mice by injecting the hybridoma cell. Antibody was purified using a Protein A-sepharose column kit (Bio-Rad Laboratories). The purity of the antibody was confirmed by HPLC (high-performance liquid chromatography) by demonstrating a single peak (data not shown).
For the labeling, colloidal gold was absorbed by an antibody following the common procedure. 22 Briefly, 0.01% hydrogen tetrachloroaurate (III) (HAuCL4) was prepared and mixed with 1% sodium citrate (C6H8O7). The mixture was boiled for 10 min, cooled to 20 C and the pH was adjusted to pH 9.15 by the drop-wise addition of potassium carbonate (K2CO3). Next, the anti-PCB antibody was added to the solution, and reacted for 2 min. Next, 10% BSA was added to the solution to block any remaining gold particles. Finally, the colloidal gold-labeled anti-PCB antibody was separated by centrifugation at 9000 rpm at 25 C.
Biosensor solid phase Figure 1 shows the system of the PCB biosensor. For the new antibody, a membrane (31ET-Chr from GE Healthcare, USA) was coated with a previously used dichlorophenol BSA conjugate 12 for the separation of PCB binding antibody and free antibody.
Briefly, one solution consisting of DMSO supplemented with 10 μg/mL of succinimidyl 6-(3,4 dichlorophenoxy) hexanoate (designated S1) synthesized from 3,4-dichloro-phenol and the other solution consisted of borate buffer (100 nM, pH 9.8) supplemented with 1.7 mg/mL of BSA were mixed at 4 C in darkness overnight. The complex, referred to as S1-BSA, was purified through a desalting column with PBS (pH 7.4) to remove any unreactive S1. The concentration of synthesized S1-BSA in the purification was measured by NanoDrop 1000 from Thermo Fisher Scientific Inc. (DE). Finally, the membrane was soaked into the S1-BSA conjugate solution while gently mixing overnight for coating.
Pretreatment
Aroclors were extracted from transformer oil using a two-column method that we newly developed for this purpose (Fig. 1) . The first column contained four layers (an established method used for Japanese oil); the first and third layers consisted of anhydrous sodium sulfate (0.5 g), the second layer was oleum-impregnated silicagel (2 g) and the bottom layer was amino-propyl-silicagel (1.5 g). The second column (we newly developed) consisted of two layers; the top layer consisted of anhydrous sodium sulfate (0.5 g) and the bottom layer consisted of silver nitrate (0.2 g).
In use, 0.25 g of the oil to be tested was added to the first column. Next, 0.2 mL of n-hexane was added to the column to promote the infiltration of the oil into the second layer. Three minutes were allowed for the reaction between the oleum and hydrocarbon chains in the oil, and then 10 mL of n-hexane was added to the first column and all of the liquid that passed the first and second column was collected. Next, 0.25 mL of DMSO was added to the liquid, and the n-hexane was evaporated on a rotary evaporator with a hot-water bath at 40 C. Finally, the remaining liquid (insulation oil and DMSO) was centrifuged (10000 rpm, 1 min) and 0.15 mL of the DMSO was collected.
Measurement
For the measurement, the collected DMSO was diluted in PBSB containing the labeled antibody plus additional pure DMSO to keep the final concentration of DMSO at 2%. The labeled antibody concentration (150 pM) was decided by experiment (data not shown) following a method previously reported. 16 The mixture was left for 30 min or more, to allow the Aroclor and the antibody to react; then, the mixture was flowed through the detection cell that contained the membrane coated with S1-BSA. Antibody binding to the membrane was inhibited by Aroclors in the sample, resulting in a reduction of the red color of the label staining the membrane. Aroclor concentration was calculated as described previously. 16 Briefly, the relative response (membrane absorbance measured for unknown sample divided by membrane absorbance of a zero Aroclor sample) was compared to a calibration curve (measured for each production lot of the antibody) prepared previously with known concentrations of Aroclors.
Instrumental analysis
High-resolution gas chromatography/high-resolution mass spectrometry (HRGC/HRMS) work was carried out using the Japanese standard procedure. 23 Transformer oil samples were also analyzed using the Korean waste official method (KOM).
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Results and Discussion
Antibody
PCBs added to transformer oil in Korea consisted of four Aroclor mixtures (Ar1242, Ar1248, Ar1254, and Ar1260) composed mainly of three, four, five, and six chlorine homologues, respectively. These are generally coexistent in the transformer oil, but not all are guaranteed to be present in a given sample or at any particular mix ratio. Regulations in Korea (as well as in the U. S. and Japan) are not composition dependent, but specify parts per million on a total weight basis. The highly specific nature of antibodies means that antibodies recognize different congeners with different degrees of reactivity. This results in a situation where some PCB congeners "count more" in the immunoassay, and results are inherently ambiguous in terms of the total PCB weight.
Mice were immunized with a mixture of 4 and 5 chlorine PCB-KLH conjugates (described in the experimental section), and the mixed nature of the injected conjugate may have played a role in our success in finding a monoclonal anti-PCB antibody (OD8B11; hereinafter referred to as the OD antibody) capable In the Japanese PCB biosensor system developed by our group, 0.5 ppm of Kanechlor can be measured using the K2A antibody, 16 so it seems likely that the new antibody will be capable of the 2 ppm sensitivity anticipated for Korea.
Pretreatment
As the first step of the pretreatment development, a previous method developed for mineral oil in Japan, was applied to Korean samples. However, we encountered a significant number of cases where the immunoassay indicated much higher concentrations of Aroclors than were actually present. The reason for high signals was suspected to be inactivation and/or denaturing of antibody by the generation of turbid materials in aqueous solvent prior to performing the immunoassay. The identification of a turbid materials component was done with the Korean oil samples on GC/FID (flame ionization detector) analysis (data not shown). The analysis concluded that the Korean transformer oil samples contain materials similar to synthetic oils (Fig. 3A) .
Therefore, a new pretreatment procedure to remove synthetic oil-like matrix constituents was needed for immunoassay for Korean samples.
In Korea, the official pretreatment method for extracting PCBs from oil was an alkali treatment, liquid-liquid extraction, a sulfuric acid treatment and silicagel column cleanup. This pretreatment is effective, but time consuming (1 or 2 samples per day). 25 Another rapid pretreatment method (heating of the multilayer silicagel column/alumina column method) of GC-ECD achieved 24 samples per day, 25 but it is not sufficiently fast for use in screening.
To make use of an advantage of the selectivity of the immunoassay, we designed a new rapid pretreatment method based on the four-layer column pretreatment. By adopting the two-column approach described in the Experimental section above, we were able to minimize the effect of up to 10% of each of the additives of reduce time (more than 80 samples per day) compared to the Korean official method and the rapid pretreatment method. The results are summarized in Fig. 3 , Fig. 2 Response curves for OD8B11 antibody reacting with four kinds of Aroclor. The symbols , , , and are Ar1242, Ar1248, Ar1254, and Ar1260. All data were measured by KinExA, and the relative response was calculated by the percentage of zero Aroclor a standard. Each curve was calculated from the best-fit Kd for each data set. Fig. 3 Effect of coexisting synthetic oils in mineral oil on the PCB biosensor response. Six kinds of synthetic oil listed in panel A were mixed with mineral oil. Diagonal striped bars, gray-tone bars and horizontal striped bars represent 10, 20 and 50% of each of synthetic oil added to the mineral oil, respectively. The solid horizontal line represents 100% pure mineral oil. These mixed oils were individually treated with the two-column system described in the Experimental section, and the resultant extract was suspended into a gold-labeled antibody solution. The solution was flowed through the detection cell, and absorbance was measured. Panel B shows the response to zero PCB mixed oil samples, and panel C shows the relative response to 1 ppm of mixed Aroclors (equal weight of Ar1242, Ar1248, Ar1254 and Ar1260) as a percentage of the corresponding zero Aroclor mixed oil respectively. The bars in the panels represent the average of triplicate determinations performed as individual experiments, and the error bars indicate ± 1 SD. which shows that up to 10% of any of the synthetic oils, except for polybutene, does not significantly affect the zero PCB absorbance response. In Fig. 3C , it is apparent that the additives do additionally slightly suppress the response to 1 ppm. Our interpretation is that the oleum in the first column reacts with and degrades mineral oil and some of the synthetic oil compounds, but synthetic oil compounds are still left. The AgNO3 (which turns brown during the pretreatment, and is known to react with sulfur compounds and aliphatic hydrocarbons 26 ) in the second column reacts with remaining synthetic oil compounds, while preventing them from inhibiting the subsequent reaction between PCBs and antibody. Since the PCB biosensor response is inhibited by the presence of PCBs, the matrix-caused suppression is expected to cause a slight overestimation of the PCBs present. While obviously not ideal, an overestimation by the PCB biosensor would lead to false positives in the screening, which are expected to be caught in confirmatory screening. This situation is preferable to false negatives, which could result in contaminated samples escaping notice.
Comparison to HRGC/HRMS
A standard curve for calculating the Aroclor concentration in transformer oil was made using seven concentrations (0.2, 0.5, 1, 2, 4, 10 and 100 mg/kg) of mixed Aroclors. As shown in Fig. 4 , the IC50 value (50% inhibitory concentration) was 1.33 mg/kg in the standard curve, suggesting that the PCB biosensor can be expected to readily detect 2 mg/kg (Korean regulation) in Korean transformer oil even those containing small amounts of synthetic oils.
We took a subset of 30 Korean transformer oil samples selected at random from the 500 samples described below, and had them measured using HRGC/HRMS to obtain the most accurate possible picture of their actual PCB levels. The same 30 samples were also measured using the PCB biosensor and standard curve. The results are summarized in Fig. 5 . Figure 5A shows the result of 30 samples measured using the previous pretreatment (developed for Kanechlor in Japan). Figure 5B shows the same samples measured using the newly developed pretreatment with a dramatic improvement in performance. The overall correlation is good with a slope of 0.93, an intercept of -0.13, and a coefficient of determination (r 2 ) of 0.84. We speculate that the remaining divergent points may be the result of the transformer oil matrix effects, which we reduced, but did not eliminate using the extraction method described above.
Screening
For screening analysis we collected and measured 500 Korean transformer oil samples by both the PCB biosensor and KOM, and compared the results. For evaluation purposes, different cutoff levels (a concentration as measured by the immunoassay described above, in which samples were considered to be positive for PCB contamination) were applied and samples were divided into positive and negative screening groups for each cutoff. Results were validated by comparisons to the KOM measurements. Samples judged positive by the immunoassay, but with less than 2 ppm as measured by the KOM, were counted as false positives (FP). On the other hand, negative samples (as judged by the immunoassay) that were contaminated PCBs (greater than 2 ppm by the KOM) were counted as false negatives (FN). The FP rate (number of FP/the number of negative samples measured by the KOM) and FN rate (number of FN/the number of positive samples as measured by KOM) were calculated, and changes of the FN rate and the FP rate were plotted as a function of the cutoff level. The screening results are summarized in Fig. 6 .
The overall screening performance is good, but we have noticed there is an apparent positive bias in Fig. 6A i.e. the PCB biosensor consistently overestimates the PCB content compared to the KOM (a slope of 1.26, intercept of 0.24, and r 2 of 0.60). The bias results in a situation where the PCB biosensor can give a good FN rate of 2.5%, even using the MRL as a cutoff. If the bias were eliminated, the FN rate of the assay using a cutoff of 2 ppm would rise, as can be seen by considering the effect of shifting the data in Fig. 6A to be closer to the ideal (slope of 1) line. As is usual in screening, the FN rate can always be reduced to zero by using a sufficiently low cutoff level, albeit at the expense of accepting a higher FP rate. If we can accept a 2.5% FN rate, we can dramatically cut down on the number of samples that have to be measured using the more time consuming and expensive official method.
It is worth noting that the 500 Korean transformer oil samples used here were chosen with concentrations of around 2 ppm, and do not reflect the overall distribution of contaminated samples in Korea. This was done to rigorously test the ability of the PCB KOM. Furthermore, it is well known that the screening assay performance is strongly influenced by the PCB distribution of the samples. 27 Another source 28 suggests that the actual population (based on a much larger sample of 64077 Korean transformer oil samples) may be somewhat more polarized with fewer samples in the vicinity of the MRL. For a comparison, Fig. 7 shows the data of 500 samples assigned into the bins used by Kim et al. 28 along with their data for comparison. If the distribution is polarized into discreet groups far from the MRL, then a better screening performance, sometimes including an ideal performance of zero FN and zero FP, can be expected. 
